Eagle Asset Management Inc Verastem, Inc. Transaction History

Eagle Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.92 - $11.16 $186,395 - $2.26 Million	-202,604 Reduced 3.64%	5,369,029 $4.56 Million
Q2 2022 Aug 10, 2022	BUY	$1.02 - $1.83 $961,125 - $1.72 Million	942,280 Added 20.35%	5,571,633 $6.46 Million
Q1 2022 May 12, 2022	BUY	$1.06 - $2.1 $250,449 - $496,173	236,273 Added 5.38%	4,629,353 $6.53 Million
Q4 2021 Feb 11, 2022	BUY	$2.05 - $3.2 $5.75 Million - $8.98 Million	2,805,850 Added 176.78%	4,393,080 $9.09 Million
Q3 2021 Nov 10, 2021	BUY	$2.54 - $4.07 $4.03 Million - $6.46 Million	1,587,230 New	1,587,230 $4.89 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.